Graves'orbitopathy strabismus surgery Quality of life
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. GO-patients, who are clinically and biochemically euthyroid for at least three months; 2. GO-patients, who show a stable orthoptic picture for at least three months: Stable means no greater than 5 prism dioptres change in primary position and no greater change in duction as 8°.
Exclusion criteria
Exclusion criteria: 1. GO-patients with suppression (inhibition of the image of the deviating eye in the visual cortex); 2. Presence of previously diagnosed and/or treated for squint not related to the thyroid; 3. Presence of vision less than 0,2 for one or both eyes.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome measure will be the correlation between the changes in the field of BSV and QoL. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes will be the influence on primary outcome of squint angle, ductions and cyclodeviation. Also, the influence of prior treatment (for instance orbital decompression) on field of BSV, change in proptosis and lid aperture and the number of complications will be recorded. | — |
Contacts
Meibergdreef 9